Wednesday, July 8, 2026

Patent intelligence · US

US 10897915

Method for making coffee products containing cannabis ingredients

granted A61KA61K2236/00A61K2236/33A61K31/00
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 15
Applicant portfolio 38
Patent details — US 10897915
Jurisdiction
US
Status
granted
Grant date
Jan 26, 2021
Expiration
Jan 21, 2041
Claims
5
CPC classes
A61K, A61K2236/00, A61K2236/33, A61K31/00
View on Google Patents ↗

Quick answer

US 10897915 (Method for making coffee products containing cannabis ingredients) is held by Blacklist Holdings, Inc.. Status: granted. Granted Jan 26, 2021. Expires Jan 21, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
5
CPC classes
A61K, A61K2236/00, A61K2236/33, A61K31/00, A61K31/352, A61K31/658

More from Blacklist Holdings, Inc.

Related pharmaceutical patents in our USPTO index.

  1. US 12343394

    CD38 modulating antibody agents

    BLACK BELT THERAPEUTICS LIMITED · Expires Jun 26, 2045

    granted
  2. US 12325699

    Antibacterial compounds

    BLACKSMITH MEDICINES, INC. · Expires Jun 5, 2045

    granted
  3. US 12304964

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED · Expires May 15, 2045

    granted
  4. US 12187754

    LpxC inhibitors and uses thereof

    BLACKSMITH MEDICINES, INC. · Expires Jan 2, 2045

    granted
  5. US 12161717

    CD38 modulating antibody agents

    BLACK BELT THERAPEUTICS LIMITED · Expires Dec 5, 2044

    granted
  6. US 12162949

    CD38 antibody

    BLACK BELT THERAPEUTICS LIMITED · Expires Dec 5, 2044

    granted
  7. US 11897873

    Kappa opioid receptor antagonists and products and methods related thereto

    BLACKTHORN THERAPEUTICS, INC. · Expires Feb 8, 2044

    granted
  8. US 11780930

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED · Expires Oct 5, 2043

    granted

Frequently asked questions

What is US patent 10897915?

US 10897915 (Method for making coffee products containing cannabis ingredients) is held by Blacklist Holdings, Inc.. Status: granted. Granted Jan 26, 2021. Expires Jan 21, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 10897915?

Blacklist Holdings, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 38 pharmaceutical patents for this assignee.

When does US 10897915 expire?

Our index shows an expiration date of Jan 21, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.